Samarth Lifesciences Deal: Quadria Capital Aur Promoters Mein Valuation Ka Bada Panga!

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAarav Shah|Published at:
Samarth Lifesciences Deal: Quadria Capital Aur Promoters Mein Valuation Ka Bada Panga!
Overview

Arre yaar, Samarth Lifesciences mein ek badi deal hone wali hai! Sunne mein aa raha hai ki Quadria Capital aur kuch aur private equity firms is critical care drug maker mein **80-85% stake** khareedne ki soch rahi hain. Deal ki valuation **₹4,500 crore** tak ja sakti hai.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Deal mein Valuation ka Bada Panga

Lekin bhai, yahan ek bada panga hai - valuation. Pichli baar bhi EQT, TPG, KKR aur Warburg Pincus jaise bade players isliye deal nahi kar paaye, kyunki promoters ko jo price chahiye tha woh buyers ko zyada laga. Ab bhi wahi situation hai. Promoters FY26 ke liye Rs 160-170 crore ke Ebitda par 30x multiple chaah rahe hain, par buyers ko yeh price bahut zyada lag raha hai.

Samarth Lifesciences Ka Dumdaar Performance

Par Samarth Lifesciences bhi kuch kam nahi hai. Yeh company 1963 se critical care drugs bana rahi hai. Sales ₹727 crore hai aur growth rate 16% CAGR se badh rahi hai, jo industry ke 10-12% growth se kaafi zyada hai. Injectables aur sterile products mein toh inki pakad mazboot hai, aur international sales bhi badh rahi hain.

Aage Badhne Ke Liye Capital Ki Zaroorat

Company ko ab aage badhne ke liye naye paisa chahiye, jaise naye manufacturing facilities lagana aur domestic market share badhana. Deal hui toh promoters 15-20% stake apne paas rakhenge aur company se jude rahenge. Promoters ko O3 Capital is deal mein advise kar raha hai.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.